Results - Announcements
OneSource Specialty Pharma Ltd share price inched up 4.77% to Rs 1396.3 after the company's net profit jumped 129.92% to Rs 57.48 crore, while revenue from operations increased 14.97% to Rs 516.24 crore in Q3FY26 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.54 lakh crore, rising 3.42%. It has marginally improved by 0.07% over last one week and softened by 3.01% in last one month while the market capitalization of OneSource Specialty Pharma Ltd has improved by 1.22% and 20.12% in the same period respectively.
Profit before tax (PBT) of OneSource Specialty Pharma Ltd stood at Rs 52.87 crore in Q3 FY26, expanding by 821.08% year-on-year, and rallying 160.57% quarter-on-quarter. EBITDA came in at Rs 162 crore, jumping 56.91% YoY and surging by 35.79% sequentially.
Total expenses grew marginally by 7.69% to Rs 428.0 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 152.25 crore, posting a minor increase of 7.83% YoY, while employee benefits expense was at Rs 77.58 crore, witnessing a strong rise of 12.96% YoY.
For the TTM ended FY26, revenue from operations declined slightly by 1.61% to Rs 1421.59 crore, while net profit surged by 327.08% to Rs 73.8 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 45325% to Rs 289.2 crore, and PBT soared 37.11% to Rs 91.96 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 8.52 crore in FY26, as against Rs 67.85 crore in FY25.
OneSource Specialty Pharma Ltd plunged by 22.77% in last one year, underperforming the benchmark BSE Sensex which has slipped by 13.18% during the same period.